Figure 1 (Susvimo 01)
Susvimo Injection, Solution
Product Images NDC 50242-078
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 100 technical images submitted to the FDA as part of the official labeling for Susvimo (NDC 50242-078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Susvimo 01a
Figure 2 (Susvimo 02)
Figure 3 (Susvimo 03)
Figure 4 (Susvimo 04)
Figure 5 (Susvimo 05)
Figure 6 (Susvimo 06)
Figure 7 (Susvimo 07)
Figure 8 (Susvimo 08)
Figure 9 (Susvimo 09)
Figure 10 (Susvimo 10)
Image (Susvimo 100)
Image (Susvimo 101)
Image (Susvimo 102)
Image (Susvimo 103)
Image (Susvimo 104)
Image (Susvimo 105)
Image (Susvimo 106)
Image (Susvimo 107)
Image (Susvimo 108)
Image (Susvimo 109)
Figure 11 (Susvimo 11)
This description is too short to provide any context or useful information.*
Image (Susvimo 110)
Image (Susvimo 111)
Image (Susvimo 112)
This is a form titled "Susvimo™ Implant Card" that is used to record information about a patient's implantation procedure. It includes fields for the patient name, physician name, clinic name and phone number, as well as the date of the implantation procedure and the implant LOT number. This information is likely used for tracking and monitoring purposes by healthcare providers.*
Figure 1 (Susvimo 113)
The text seems to be a description of a product called "Susvimo™ Explant tool" which includes one tool for explantation and one instruction document for implant removal procedure. The text does not provide a lot of detail on the product beyond this.*
Figure 2 (Susvimo 114)
The text describes "Finger grips" and "Contoured tips". It is likely that the text is referring to a type of product or object that includes these features. However, without additional context, it is difficult to determine the specific use or application of these features.*
Image (Susvimo 115)
Figure 3 (Susvimo 116)
Figure 4 (Susvimo 117)
Figure 5 (Susvimo 118)
Figure 6 (Susvimo 119)
Figure 12 (Susvimo 12)
Image (Susvimo 120)
Figure 7 (Susvimo 121)
Figure 8 (Susvimo 122)
Figure 9 (Susvimo 123)
Figure 10 (Susvimo 124)
Image (Susvimo 125)
Figure 11 (Susvimo 126)
Image (Susvimo 127)
Figure 12 (Susvimo 128)
Image (Susvimo 129)
Figure 13 (Susvimo 13)
Image (Susvimo 130)
Image (Susvimo 131)
Image (Susvimo 132)
Image (Susvimo 133)
Image (Susvimo 134)
Image (Susvimo 135)
Image (Susvimo 136)
Image (Susvimo 137)
Principal Display Panel (Kit Carton)
This is a description of Susvimo, a medication that comes in a vial containing 10 mg/0.1 mL ranibizumab, used in combination with Susvimo ocular implant. This medication is available in a single-dose vial and requires an insertion tool assembly. Dispensing the enclosed medication guide to each patient is advised. NDC code is 50242-078-55.*
Principal Display Panel (10 mg/0.1 mL Vial Carton)
This is a medication with the brand name Susvimo, which is ranibizumab injection supplied in a vial that contains 10 mg/0.1 mL of ranibizumab. The vial has an NDC number of 50242-078-12 and manufactured by Genentech. This medication is used in conjunction with Susvimo ocular implant. It is essential to dispense the enclosed Medication Guide to each patient.*
Figure 14 (Susvimo 14)
Figure 15 (Susvimo 15)
Figure 16 (Susvimo 16)
Susvimo 16a
Figure 17 (Susvimo 17)
Figure 18 (Susvimo 18)
Figure 19 (Susvimo 19)
Figure 20 (Susvimo 20)
Figure 21 (Susvimo 21)
Figure 22 (Susvimo 22)
Figure 23 (Susvimo 23)
Figure 24 (Susvimo 24)
Figure 25 (Susvimo 25)
Figure 26 (Susvimo 26)
Figure 27 (Susvimo 27)
Figure 28 (Susvimo 28)
The text is a description of a Carton that contains SUSVIMO™ (ranibizumab injection) refill needle in 100 mg/mL sterile blister. It includes one SUSVIMO™ (ranibizumab injection) vial, one refill needle, and one Prescribing Information.*
Figure 29 (Susvimo 29)
Figure 30 (Susvimo 30)
Figure 31 (Susvimo 31)
Figure 1 (Susvimo 32)
This text describes a packaging product for Susvimo™ (ranibizumab injection) and assembly, which includes an insertion tool, initial fill needle kit, implant, procedure IFU, and a 100 mg/mL vial. It also mentions the availability of a Susvimo™ explant tool and US Prescribing Information.*
Figure 2 (Susvimo 33)
Figure 3 (Susvimo 34)
The text describes a medical element for release control. It includes a silicone encasing body and an extrascleral flange with a septum. The element is available in sizes 26mm and 46mm with a diameter of 8.4mm.*
Figure 4 (Susvimo 35)
The text appears to be describing some medical equipment, specifically a set of guides for implants or surgeries. It mentions a "Luer Guide" and a "lock slot" with a sleeve, possibly indicating a part that holds a needle or other tool in place. Additionally, there is something called an "Implant Gripper Guide" with "tips channel," which could refer to a device used to position or manipulate an implanted object. Overall, the text seems to provide some technical details about medical instruments, but without further context or images it is difficult to fully understand their purpose or use.*
Figure 5 (Susvimo 36)
Figure 6 (Susvimo 37)
Figure 7 (Susvimo 38)
Image (Susvimo 39)
Image (Susvimo 40)
Figure 8 (Susvimo 41)
Image (Susvimo 42)
Figure 9 (Susvimo 43)
The text appears to be a diagram with labels for the positions of objects or body parts, probably related to anatomy or biology, but without further context, it is not clear what the objects are.*
Figure 10 (Susvimo 44)
Figure 11 (Susvimo 45)
Image (Susvimo 46)
Figure 12 (Susvimo 47)
Image (Susvimo 48)
Susvimo 48a
Figure 13 (Susvimo 49)
Image (Susvimo 50)
Figure 14 (Susvimo 51)
Figure 15 (Susvimo 52)
Figure 16 (Susvimo 53)
Image (Susvimo 54)
Figure 17 (Susvimo 55)
Image (Susvimo 56)
Figure 18 (Susvimo 57)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
